Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02231723
Title A Study of BBI608 in Combination With Gemcitabine and Nab-Paclitaxel in Adult Patients With Metastatic Pancreatic Adenocarcinoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boston Biomedical, Inc
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Arizona Phoenix Arizona 85054 United States Details
Emory University Winship Cancer Institute Atlanta Georgia 30322 United States Details
Parkview Research Center Fort Wayne Indiana 46845 United States Details
Indiana University Health Goshen Center for Cancer Care Goshen Indiana 46526 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
Comprehensive Cancer Centers of Nevada Henderson Nevada 89014 United States Details
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
The University of Tennessee Medical Center Knoxville Tennessee 37920 United States Details
Texas Oncology - Austin Midtown Austin Texas 78705 United States Details
Texas Oncology - Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Texas Oncology - SAT&BC San Antonio Texas 78216 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field